BrightInsight
BrightInsight provides a digital health platform specializing in solutions for the biopharma and medtech industries, including Disease Management, SaMD, and Data & Insights, and is recognized among Newsweek’s World’s Best Digital Health Companies 2024.
Services
BrightInsight offers a digital health platform designed specifically for the biopharma and medtech industries. The company provides a range of solutions, including Disease Management and Software as a Medical Device (SaMD). Additionally, their Data & Insights services cater to the growing need for actionable data in the healthcare sector. The platform supports tailored therapeutic solutions for various health conditions such as diabetes, oncology, and immunology.
Products
BrightInsight has developed 14 Software as a Medical Device (SaMD) solutions that are critical for modern healthcare. These SaMD products are designed to enhance disease management and provide comprehensive insights into patient data. They are a key component of their digital health platform, helping to manage complex medical conditions effectively.
Therapeutic Areas
BrightInsight operates across 11 different therapy areas. Their solutions address major health conditions including diabetes, oncology, and immunology. By offering specialized therapeutic area solutions, the company aims to improve patient outcomes and provide better management options for chronic and acute conditions.
Industry Partnerships
BrightInsight collaborates with 6 out of the top 10 biopharma companies. These partnerships enable the company to leverage cutting-edge research and technology to enhance their digital health platform. Through these collaborations, BrightInsight is able to deliver innovative solutions that meet the high standards of the biopharma industry.
Recognition
BrightInsight has been recognized among Newsweek’s World’s Best Digital Health Companies 2024. This recognition underscores the company's commitment to excellence in digital health and its impactful contributions to the biopharma and medtech industries.